IL27 and colorectal carcinoma: In relation to IL-27 and CRC, it has been described as a cytokine with antitumor effects, showing not only antiproliferative and antiangiogenic effects by acting directly on cancer cells, but also having indirect antitumor effects driven by immunostimulatory activity in this and other types of cancer [69].